165
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Serum Vitamin D Levels as Biomarkers in Patients with Autoimmune Uveitis and their Possible Correlation with Disease Activity

, MDORCID Icon, , MD, PhD, , MD, , MDORCID Icon, , MD, PhDORCID Icon, , MD, PhDORCID Icon, , MD, PhD & , MD, PhDORCID Icon show all
Pages 628-635 | Received 01 Sep 2022, Accepted 21 Feb 2023, Published online: 21 Mar 2023

References

  • Cunningham ET, Jr., Lietman TM, Whitcher JP. Blindness: a global priority for the twenty-first century. Bull World Health Organ. 2001;79(3):180. PMID: 11285659, PMCID: PMC2566376.
  • Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007 May–June;55(3):173–183. doi:10.4103/0301-4738.31936. PMID: 17456933.
  • Gonzalez Fernandez D, Nascimento H, Nascimento C, Muccioli C, Belfort R. Uveitis in São Paulo, Brazil: 1053 new patients in 15 months. Ocul Immunol Inflammation. 2017;25(3):382–387. doi:10.3109/09273948.2015.1132741.
  • Nussenblatt RB. Basic and clinical immunology in uveitis. Jpn J Ophthalmol. 1987;31:368–374.
  • Ke Y, Liu K, Huang GQ, et al. Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol. 2009;182(5):3183–3190. doi:10.4049/jimmunol.0802487.
  • Mitulescu TC, Stavaru C, Voinea LM, Banica LM, Matache C, Predeteanu D. The role of vitamin D in immuno-inflammatory responses in ankylosing spondylitis patients with and without acute anterior uveitis. J Med Life. 2016;9:26–33.
  • Sengler C, Zink J, Klotsche J, et al. Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis-data from a German inception cohort [published online ahead of print December]. Arthritis Res Ther. 2018;20(1):276. doi:10.1186/s13075-018-1765-y.
  • Sumethkul K, Boonyaratavej S, Kitumnuaypong T, et al. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33(6):1461–1467. doi:10.1007/s00296-012-2537-7.
  • Di Franco M, Barchetta I, Iannuccelli C, et al. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12-month follow-up study. BMC Musculoskelet Disord. 2015;16(1):53. doi:10.1186/s12891-015-0505-6.
  • Simpson S, Jr., Taylor B, Blizzard L, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68(2):193–203. doi:10.1002/ana.22043.
  • Stein MS, Liu Y, Gray OM, et al. A randomized trial of high- dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 2011;77(17):1611–1618. doi:10.1212/WNL.0b013e3182343274.
  • Constantinescu CS, Lavi E. Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Curr Eye Res. 2000;20(1):71–76. doi:10.1076/0271-3683(200001)2011-HFT071.
  • Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflammation. 2001;9(2):93–102. doi:10.1076/ocii.9.2.93.3975.
  • Reins RY, McDermott AM. Vitamin D: implications for ocular disease and therapeutic potential. Exp Eye Res. 2015;134:101–110. doi:10.1016/j.exer.2015.02.019.
  • Tang J, Zhou R, Luger D, et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol. 2009;182(8):4624–4632. doi:10.4049/jimmunol.0801543.
  • Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. [published online ahead of print July].Nutrients. 2020 15;12(7):2097. doi:10.3390/nu12072097. PMID: 32679784, PMCID: PMC7400911.
  • Chiu ZK, Lim LL, Rogers SL, Hall AJ. Patterns of vitamin D levels and exposures in active and inactive noninfectious uveitis patients. Ophthalmology. 2020;127(2):230–237. doi:10.1016/j.ophtha.2019.06.030.
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053.
  • Saúde MD, Conselho Nacional de Saúde. Brasilia, Brasil. Brasília: diário oficial da união, resolution no. 466. http://conselho.saude. Published December 12, 2012. http://gov.br/resolucoes/2012/reso466.pdf. (Health, M. D., & Conselho Nacional de Saúde. (published December 12, 2012). Brasilia, Brazil. Brasília: official diary of the union, resolution no. 466. Retrieved from http://conselho.saude. Retrieved from http://gov.br/resolucoes/2012/reso466.pdf
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
  • Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflammation. 2008;16(1):1–2. doi:10.1080/09273940801899822.
  • Kimlin MG, Lucas RM, Harrison SL, et al. The contributions of solar ultraviolet radiation exposure and other determinants to serum 25-hydroxyvitamin D concentrations in Australian adults: the AusD study. Am J Epidemiol. 2014;179(7):864–874. doi:10.1093/aje/kwt446.
  • Nimitphong H, Holick MF. Vitamin D status and sun exposure in Southeast Asia. Dermatoendocrinol. 2013;5(1):34–37. doi:10.4161/derm.24054.
  • Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014;9(11):e111265. doi:10.1371/journal.pone.0111265.
  • Hyppönen E, Boucher BJ. Vitamin D, obesity, and the metabolic syndrome. In: Feldman D, (ed.). Vitamin D. 4th ed. Cambridge: Academic Press; 2018:425–444.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385.
  • Sobrin L, Stanwyck LK, Pan W, Hubbard RA, Kempen JH, VanderBeek BL. Association of hypovitaminosis D with increased risk of uveitis in a large health care claims database. JAMA Ophthalmol. 2018;136(5):548–552. doi:10.1001/jamaophthalmol.2018.0642.
  • Bae JH, Choe HJ, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity: vitamin D and COVID-19: a narrative review. Rev Endocr Metab Disord. 2022;23(3):579–599. doi:10.1007/s11154-021-09705-6.
  • Muñoz A, Grant WB. Vitamin D and cancer: an historical overview of the epidemiology and mechanisms. Nutrients. 2022;14(7):1448. doi:10.3390/nu14071448.
  • Degerud E, Nygård O, De Vogel S, et al. Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. J Clin Endocrinol Metab. 2018;103(3):1161–1170. doi:10.1210/jc.2017-02328.
  • Tian Y, Wang C, Ye Z, Xiao X, Kijlstra A, Yang P. Effect of 1, 25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behcet’s disease. Invest Ophthalmol Vis Sci. 2012;53(10):6434–6441. doi:10.1167/iovs.12-10398.
  • Yi X, Yang P, Sun M, Yang Y, Li F. Decreased 1, 25-dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt–Koyanagi-Harada (VKH) disease. Mol Vis. 2011;17:673–679.
  • Dadaci Z, Cetinkaya S, Oncel Acir N, Oncel M, Borazan M. Serum vitamin D levels in patients with acute anterior uveitis. Ocul Immunol Inflammation. 2017;25(4):492–496. doi:10.3109/09273948.2016.1139735.
  • Grotting LA, Davoudi S, Palenzuela D, Papaliodis GN, Sobrin L. Association of low vitamin D levels with noninfectious anterior uveitis. JAMA Ophthalmol. 2017;135(2):150–153. doi:10.1001/jamaophthalmol.2016.4888.
  • Llop SM, Davoudi S, Stanwyck LK, et al. Association of low vitamin D levels with noninfectious uveitis and scleritis. Ocul Immunol Inflammation. 2019;27(4):602–609. doi:10.1080/09273948.2018.1434208.
  • Cunningham ET, Jr., Sobrin L, Hall AJ, Zierhut M. Vitamin D and ocular inflammation. [published online ahead of print April]. Ocul Immunol Inflammation. 2020 2;28(3):337–340. doi:10.1080/09273948.2020.1734421. PMID: 32255412.
  • Pillar S, Amer R. The association between vitamin D and uveitis: a comprehensive review. Surv Ophthalmol. 2022;67(2):321–330. doi:10.1016/j.survophthal.2021.07.006. PMID: 34343538.
  • Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002;9(1):87–98. doi:10.1097/00060793-200202000-00011.
  • Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18(2):153–165. doi:10.1007/s11154-017-9424-1.
  • Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D- lightful story. J Bone Mineral Res. 2007;22(Suppl. 2):V28–33. doi:10.1359/jbmr.07s211.
  • Leal ACGB, Corrêa MP, Holick MF, Melo EV, Lazaretti-Castro M. Sun-induced production of vitamin D3 throughout 1 year in tropical and subtropical regions: relationship with latitude, cloudiness, UV-B exposure and solar zenith angle. [published online ahead of print February]. Photochem Photobiol Sci. 2021;20(2):265–274. doi:10.1007/s43630-021-00015-z.
  • Lee DJ, Muhammad FY, Wang D. Obesity exacerbates experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2018;59:2552–2552.
  • Guo X, Chen Z, Xing Y. Immune-mediated uveitis and lifestyle factors: a review. Ophthalmic Res. 2021;64(5):687–695. doi:10.1159/000518496.
  • Multicenter Uveitis Steroid Treatment Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010;149(4):550.e561.e510.
  • Malaguarnera G, Scollo D, Messina A, et al. Management of chronic anterior uveitis relapses: efficacy of oral vitamin D treatment. [published online ahead of print June]. Invest Ophthalmol Vis Sci. 2017 23;58(8):1095.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.